Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01617395 · ClinicalTrials.gov registry record

Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
181
Enrollment target

NCT01617395 is a clinical trial that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 181 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01617395 has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
181 participants
Enrollment target

Study Summary

Background: \- Research shows that both genes and the environment influence a person s risk for getting multiple sclerosis (MS). However, it is not possible to accurately predict who will develop MS. Researchers want to study people with MS and their family members. They have developed a Genetic and Environmental Risk Score for MS. This score combines information from a person's medical history and genes. It also includes environmental factors that may be related to developing MS. This study will test this risk score to see if it can help predict who will develop MS. Objectives: \- To evaluate a score for genetic and environmental risk factors that may help predict whether a person will develop MS. Eligibility: * Individuals at least 18 years of age who have MS. * Individuals between 18 to 50 years of age who are the parent, brother, sister, or child of a person with MS. Design: * People with MS will allow researchers to look at their personal and medical data. These data will have been collected in other MS-related studies. * Relatives of people with MS will fill out a questionnaire and give blood and saliva samples. They will fill out the questionnaire again one year later. * Some relatives will have additional optional testing. These tests will include a physical exam and imaging studies. There may also be other tests. These tests may be repeated every 1 to 5 years for 20 years.

Trial Details

FieldValue
Enrollment Target 181 participants
Start Date 2012-08-15

What the Registry Record Tells You About NCT01617395

The ClinicalTrials.gov registry entry for NCT01617395 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01617395 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01617395 about?

NCT01617395 is a clinical study titled "Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility". Background: \- Research shows that both genes and the environment influence a person s risk for getting multiple sclerosis (MS). However, it is not possible to accurately predict who will develop MS. Researchers want to study people with MS and their family members. They have developed a Genetic an...

What is the current status of trial NCT01617395?

This trial is currently completed. The enrollment target is 181 participants. The study started on 2012-08-15.

Who is sponsoring clinical trial NCT01617395?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.